Literature DB >> 25365080

Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.

T Pincus1, J Braun, A Kavanaugh, J S Smolen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25365080

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  5 in total

1.  Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis.

Authors:  Congqi Hu; Zhao Dai; Jia Xu; Lianyu Zhao; Yanping Xu; Meilin Li; Jiahui Yu; Lu Zhang; Hui Deng; Lijuan Liu; Mingying Zhang; Jiarong Huang; Linping Wu; Guangxing Chen
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

2.  Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.

Authors:  Ayse Acar; Savas Guzel; Banu Sarifakioglu; Eda Celik Guzel; Aliye Yildirim Guzelant; Ceyda Karadag; Lebriz Kiziler
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980

3.  Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.

Authors:  Yune-Jung Park; Seung-Ah Yoo; Daehee Hwang; Chul-Soo Cho; Wan-Uk Kim
Journal:  Exp Mol Med       Date:  2016-02-26       Impact factor: 8.718

4.  Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis.

Authors:  Ji-Won Kim; Jin-Sun Kong; Saseong Lee; Seung-Ah Yoo; Jung Hee Koh; Jingchun Jin; Wan-Uk Kim
Journal:  Exp Mol Med       Date:  2020-05-27       Impact factor: 8.718

5.  Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.

Authors:  Shijia Liu; Yunke Guo; Lu Lu; Jiawei Lu; Mengying Ke; Tingting Xu; Yan Lu; Wenjun Chen; Jue Wang; Deshun Kong; Qiuxiang Shen; Youjuan Zhu; WenFeng Tan; Wei Ji; Wei Zhou
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.